Head-to-head · WeighScore
Mondae vs Potere Health MD
By GLP-1 ScorecardUpdated
Score comparison
Mondae has the higher recorded score — 74.3/100 to 72.5/100, but only just.
Mondae grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mondae shows one-, three- and six-month prices for both compounded injections. Get the payment schedule and refund terms before choosing a longer plan. Potere Health MD is close behind and may still be the better fit — see the factor split below.
Before you choose
Before comparing the headline prices, the Mondae review and the Potere Health MD review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Mondae vs Trimi and OrderlyMeds vs Potere Health MD compare each of them with another graded program, and the list of alternatives to Mondae ranks the programs closest to Mondae on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Belle Health review covers one graded close to these two, at 73.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Mondae | Potere Health MD |
|---|---|---|
| WeighScore | 74.3/100 | 72.5/100 |
| Grade | C | C |
| Site position | #69 | #87 |
| Semaglutide | $87 for 1 month (compounded; confirm billing interval) | $239 upfront for the advertised 10 mg compounded vial; usable supply varies |
| Tirzepatide | $126 for 1 month (compounded; confirm billing interval) | $119 for the advertised four-week compounded starting order or $350 upfront for the larger vial |
| Coverage | Confirm treatment availability in your state | 1 state |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Both product pages show one-month prices and display totals for longer plans
- The product pages advertise the same price across doses and no membership fee
- The terms describe a prorated refund for unshipped supply when the prescribed treatment cannot be fulfilled
What to consider
- The lowest monthly figures are six-month equivalents; the product pages do not confirm the selected debit schedule
- The refund policy describes nonrefundable consultation fees and restricts prescription cancellations after dispensing or shipping
- The two GLP-1 product pages do not establish the dispensing pharmacy for a selected order
Strengths
- Posts upfront purchase amounts for compounded options
- Advertises Utah telehealth and in-person appointments
- Discusses branded options separately
What to consider
- Monthly estimates are not the amount due at purchase
- Usable supply depends on the prescription and pharmacy label
- Ask which charges and refund rules apply to the selected order
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.